BACKGROUND & AIMS: Hepatocyte transplantation-induced liver inflammation impairs cell engraftment. We defined whether proinflammatory cytokines and chemokines played roles in regulation of hepatocyte engraftment in the liver. METHODS: We performed studies over up to 3 weeks in rat hepatocyte transplantation systems. Expression of 84 cytokine-chemokine genes was studied by quantitative real-time polymerase chain reactions. Expression of selected up-regulated genes was verified by immunohistochemistry. Hepatic recruitment of neutrophils was demonstrated by myeloperoxidase activity assays, and Kupffer cell activation was established by carbon phagocytosis assays. The role of neutrophils and Kupffer cells in regulating expression of cytokine-chemokine genes as well as cell engraftment was determined by cell depletion studies. RESULTS: Within 6 hours after syngeneic cell transplantation, expression of 25 cytokine-chemokine genes increased by 2- to 123-fold, P < .05. These genes were largely associated with activated neutrophils and macrophages, including chemokine ligands, CXCL1, CXCL2, CCL3, CCL4; chemokine receptors, CXCR1 or CXCR2, CCR1, CCR2; and regulatory cytokines tumor necrosis factor alpha and interleukin-6. Inflammatory cells in the liver immunostained for CCR1, CCR2, CXCR1, and CXCR2, which indicated that up-regulated messenger RNA was appropriately translated. When neutrophils and Kupffer cells were depleted with neutrophil antiserum and gadolinium chloride, respectively, before transplanting cells, cell transplantation-induced cytokine-chemokine responses were attenuated. Virtually all abnormalities subsided in animals treated with neutrophil antiserum plus gadolinium chloride. Moreover, depletion of neutrophils or Kupffer cells improved engraftment of transplanted cells. CONCLUSIONS: Cell transplantation-induced liver inflammation involves proinflammatory cytokine-chemokine systems capable of modulation by neutrophils and Kupffer cells. This offers new directions for optimizing cell therapy strategies.
BACKGROUND & AIMS: Hepatocyte transplantation-induced liver inflammation impairs cell engraftment. We defined whether proinflammatory cytokines and chemokines played roles in regulation of hepatocyte engraftment in the liver. METHODS: We performed studies over up to 3 weeks in rat hepatocyte transplantation systems. Expression of 84 cytokine-chemokine genes was studied by quantitative real-time polymerase chain reactions. Expression of selected up-regulated genes was verified by immunohistochemistry. Hepatic recruitment of neutrophils was demonstrated by myeloperoxidase activity assays, and Kupffer cell activation was established by carbon phagocytosis assays. The role of neutrophils and Kupffer cells in regulating expression of cytokine-chemokine genes as well as cell engraftment was determined by cell depletion studies. RESULTS: Within 6 hours after syngeneic cell transplantation, expression of 25 cytokine-chemokine genes increased by 2- to 123-fold, P < .05. These genes were largely associated with activated neutrophils and macrophages, including chemokine ligands, CXCL1, CXCL2, CCL3, CCL4; chemokine receptors, CXCR1 or CXCR2, CCR1, CCR2; and regulatory cytokines tumor necrosis factor alpha and interleukin-6. Inflammatory cells in the liver immunostained for CCR1, CCR2, CXCR1, and CXCR2, which indicated that up-regulated messenger RNA was appropriately translated. When neutrophils and Kupffer cells were depleted with neutrophil antiserum and gadolinium chloride, respectively, before transplanting cells, cell transplantation-induced cytokine-chemokine responses were attenuated. Virtually all abnormalities subsided in animals treated with neutrophil antiserum plus gadolinium chloride. Moreover, depletion of neutrophils or Kupffer cells improved engraftment of transplanted cells. CONCLUSIONS: Cell transplantation-induced liver inflammation involves proinflammatory cytokine-chemokine systems capable of modulation by neutrophils and Kupffer cells. This offers new directions for optimizing cell therapy strategies.
Authors: Gabriel T Schnickel; Sam Bastani; George R Hsieh; Ali Shefizadeh; Rubina Bhatia; Michael C Fishbein; John Belperio; Abbas Ardehali Journal: J Immunol Date: 2008-04-01 Impact factor: 5.422
Authors: S Gupta; P Rajvanshi; H Malhi; S Slehria; R P Sokhi; S R Vasa; M Dabeva; D A Shafritz Journal: Am J Physiol Gastrointest Liver Physiol Date: 2000-10 Impact factor: 4.052
Authors: Lin Ying Liu; Mary Ellen Bates; Nizar N Jarjour; William W Busse; Paul J Bertics; Elizabeth A B Kelly Journal: J Immunol Date: 2007-10-01 Impact factor: 5.422
Authors: Gil Y Melmed; Stephan R Targan; Uma Yasothan; Delphine Hanicq; Peter Kirkpatrick Journal: Nat Rev Drug Discov Date: 2008-08 Impact factor: 84.694
Authors: Andrzej R Glabinski; Bartosz Bielecki; Pawel Kolodziejski; Yulong Han; Krzysztof Selmaj; Richard M Ransohoff Journal: J Interferon Cytokine Res Date: 2003-08 Impact factor: 2.607
Authors: Tracy C Kuo; Arthur L Shaffer; Joseph Haddad; Yong Sung Choi; Louis M Staudt; Kathryn Calame Journal: J Exp Med Date: 2007-04-02 Impact factor: 14.307
Authors: Anja Mueller; Andrea Meiser; Ellen M McDonagh; James M Fox; Sarah J Petit; Georgina Xanthou; Timothy J Williams; James E Pease Journal: J Leukoc Biol Date: 2008-01-03 Impact factor: 4.962
Authors: Ruth A Roberts; Robert A Smith; Stephen Safe; Csaba Szabo; Ronald B Tjalkens; Fredika M Robertson Journal: Toxicology Date: 2010-07-17 Impact factor: 4.221